Sportstech startup Game Theory, logistics firm Omnivio, simplification platform Done Deal, microbiome company Leucine Rich Bio and Generative artificial intelligence startup InsurStaq.ai have raised early-stage funding, the companies said on Tuesday.
Game Theory
Bengaluru-based Game Theory has raised $2 million (Rs 16.6 crore) in a pre-Series A funding round led by Nithin Kamath’s Rainmatter Capital.
WEH Ventures, Prequate Advisory, tennis player Rohan Bopanna and Balakrishna Adiga also participated in the round.
Game Theory will use the fresh money to develop its core technology for skill-based matchmaking, establish coaching products, and expand the reach of smart sporting facilities across the country.
Founded by Sudeep Kulkarni, Saket and Sukrut Gejji, Game Theory uses artificial intelligence and computer vision to provide a gamified experience to users while providing a superior playing experience on-court/ on-field like automated scoring, game highlights and sports statistics.
Earlier, the company raised $500,000 in a funding round from Techstars and undisclosed angel investors.
Omnivio
Former Snapdeal executives floated e-commerce and omnichannel logistics startup Omnivio has raised $1.02 million (Rs 8.4 crore) in a seed funding round led by Caret Capital, formerly known as Supply Chain Labs.
The round also saw participation from early-stage VC firms like Blume Ventures, Eximius VC, SuniconVenture Fund, Misfits, and undisclosed angel syndicates and angel investors investors from India, the Middle East, and South East Asia.
It plans to use the funding for product development and expansion of its enterprise Go-To-Market (GTM) teams in India and the Middle East.
Founded by Sidhartha Bhimania and Anuj Jain in 2021, Omnivio is a control tower-backed logistics marketplace that connects retail enterprises and logistics providers.
Notably, the Noida-based startup had previously raised $400,000 in an angel round from 91 Ventures, Dexter Angels, Supermorpehus, and a host of angel investors in 2022.
Done Deal has secured $800,000 (Rs 6.65 crore) in a pre-seed funding round led by Nikhil Kamath and Abhijeet Pai’s proptech investment firm Gruhas.
The round also saw participation from early-stage venture capital firms, such as WeFounderCircle (WFC), Capital-A, Dezerv Innovation Fund, ICE.VC, along with undisclosed angel investors.
The startup will use the funding to accelerate product development and scale the platform along with expanding its presence across geographies.
Founded by Rohit Raj, Aneesh Sivakumar and Ankur Jain, Done Deal aims to modernise the legacy M&A process using technology. In their first phase, they are building a simple and transparent platform to enable anonymous discovery of vetted startups by potential acquirers across the globe.
Leucine Rich Bio
Microbiome company Leucine Rich Bio has raised an undisclosed amount in a pre-Series A funding round from undisclosed investors including gastroenterologists, oncologists and biotechnology entrepreneurs.
The funds will be used for marketing and development of new products.
The firm had previously raised its pre-seed funding worth Rs 2.3 crore in 2017.
Leucine Rich Bio makes products catering to the gut microbiome. It has a presence in Thailand and the Philippines, other than in India. It recently opened a microbiome-focused gut health clinic in Bengaluru.
The company witnessed 20% year-on-year growth in 2022-23, while the quarter-on-quarter growth was 30% in quarter 2 of the financial year 2023-24.
InsurStaq.ai
Generative AI startup InsurStaq.ai secured funding from InsurStaq.ai from early-stage investor Faad Network’s fintech accelerator.
Founded in 2022 by Shivam Kaushik and Mayan Kansal, InsurStaq.ai is currently focused on developing InsurGPT, a specialized large language model (LLM) tailored for the insurance industry, and it is conducting beta testing of its products with a select group of several hundred early adopters.
The company's solutions are designed to simplify complex processes and improve the overall journey for policyholders, insurers, and other stakeholders involved.
"The injection of capital will be important in accelerating the implementation of Generative AI solutions across the entire value chain of the insurance industry," said Kansal, co-founder and chief executive officer, InsurStaq.ai
